Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears
A PROSPECTIVE STUDY TO EVALUATE SURGICAL OUTCOMES IN SUBJECTS WITH FULL-THICKNESS ROTATOR CUFF TEARS TREATED BY MEANS OF A DOUBLE-ROW ARTHROSCOPIC REPAIR.
2 other identifiers
observational
162
1 country
37
Brief Summary
This is an observational study that involves subjects with full-thickness rotator cuff tears treated by means of arthroscopy surgical repair, also known as arthroscopic surgery. The primary objective of this study is to observe the timing and rate of tendon retear in those subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2008
Typical duration for all trials
37 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2008
CompletedFirst Posted
Study publicly available on registry
August 22, 2008
CompletedStudy Start
First participant enrolled
October 13, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2011
CompletedFebruary 16, 2021
February 1, 2021
2.7 years
August 21, 2008
February 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary objective is to observe the rate and timing of tendon retear in subjects with full thickness rotator cuff tears (RCTs) treated by means of arthroscopic surgery.
1 year
Secondary Outcomes (5)
Determine the correlation of functional outcomes over time in subjects with retears compared with subjects who have an intact cuff repair using the Constant Murley Shoulder Score as well as strength and range of motion.
1 year
Determination of the correlation between imaging biomarkers (muscle atrophy and fatty infiltration) and the subjects outcome (retear and function).
1 year
Estimation of the relationship between patient reported outcomes and subject's surgical and functional outcomes.
1 year
Evaluation of the ability to define
1 year
Observation of any comorbidity associated with the arthroscopic surgical procedure through the collection of adverse events to provide and SOC reference for future safety studies.
1 year
Study Arms (1)
1
Standard of Care
Interventions
Subjects return for 7 follow-up visits following arthroscopic repair of their rotator cuff. During the follow-up visits subjects undergo imaging with MRI and ultrasound.
Eligibility Criteria
Community Sample
You may qualify if:
- Full thickness Rotator Cuff Tears ranging from 1cm to 4cm in size.
- Planned procedure for repair is tendon-to-bone repair by means of an arthroscopy
You may not qualify if:
- Previous surgical intervention to the shoulder joint understudy
- Tears of the subscapularis or labral pathology requiring surgical repair
- Shoulder instability either shoulder
- Unable to complete functional evaluations in either shoulder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pfizerlead
Study Sites (37)
The Core Institute
Phoenix, Arizona, 85027, United States
Desert Valley Radiology
Phoenix, Arizona, 85032, United States
Paradise Valley Hospital
Phoenix, Arizona, 85032, United States
Desert Valley Radiology
Phoenix, Arizona, 85037, United States
Banner Boswell Imaging Center
Sun City, Arizona, 85351, United States
Banner Boswell Medical Center
Sun City, Arizona, 85351, United States
The Core Institute
Sun City, Arizona, 85351, United States
Banner Del E Webb Medical Center
Sun City West, Arizona, 85375, United States
Banner Del E Webb Outpatient Diagnostics
Sun City West, Arizona, 85375, United States
The CORE Institute-Sun City West
Sun City West, Arizona, 85375, United States
University of California, San Francisco
San Francisco, California, 94115, United States
University of California, San Francisco
San Francisco, California, 94120, United States
University of California, San Francisco
San Francisco, California, 94143-0728, United States
University of California, San Francisco
San Francisco, California, 94143, United States
University of California, San Francisco
San Francisco, California, 94158, United States
Yale University School of Medicine
New Haven, Connecticut, 06510, United States
Yale-New Haven Hospital
New Haven, Connecticut, 06520, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Massachusetts General Hospital
Waltham, Massachusetts, 02451, United States
Hospital for Special Surgery
New York, New York, 10021, United States
Mount Sinai Medical Center
New York, New York, 10029, United States
University of Rochester Medical Center
Rochester, New York, 14618, United States
University Orthopaedic Associates
Rochester, New York, 14618, United States
University of Rochester Medical Center
Rochester, New York, 14642, United States
Cleveland Clinic
Cleveland, Ohio, 44195, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
University Orthopedics
Providence, Rhode Island, 02905, United States
University Orthopedics, Inc.
Providence, Rhode Island, 02906, United States
Texas Orthopedic Specialists, PA
Bedford, Texas, 76021, United States
Orthopedic Specialists
Grapevine, Texas, 76051, United States
Preferred Imaging
Grapevine, Texas, 76051, United States
Kelsey Research Foundation
Houston, Texas, 77005, United States
Kelsey-Seybold Spring Medical and Diagnostic Center
Houston, Texas, 77014, United States
Kelsey Seybold Clinic
Houston, Texas, 77025, United States
St. Luke's Episcopal Hospital
Houston, Texas, 77030, United States
Harris Methodist Southlake
Southlake, Texas, 76092, United States
The Everett Clinic
Everett, Washington, 98201, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2008
First Posted
August 22, 2008
Study Start
October 13, 2008
Primary Completion
July 5, 2011
Study Completion
July 5, 2011
Last Updated
February 16, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\_trials/trial\_data\_and\_results/data\_requests.